In fact, it has been reported that heterozygous Becn1-deficient mice are susceptible to liver cancer, lung cancer and lymphoma [15,16], and that a single allele of BECN1 is frequently deleted in breast cancer, ovarian cancer and prostate cancer [17]. This evidence concerns the gene BECN1 and breast carcinoma.